Increased Levels of Anaphylatoxin (C5a) and Bradykinin in End-Stage Renal Disease Patients on Maintenance Hemodialysis. Potential Relevance to Heparin Mediated Hemodynamic Responses

被引：0
|
作者：
Hoppensteadt, D. A. [1 ]
Adiguzel, C. [1 ]
Cunanan, J. [1 ]
Litinas, E. [1 ]
Fareed, J. [1 ]
机构：
[1] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
来源：
CLINICAL CHEMISTRY | 2009年 / 55卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A77 / A77
页数：1
相关论文
共 50 条
  • [1] Increased levels of anaphylatoxin (C5a) and bradykinin in end-stage renal disease patients on maintenance hemodialysis. potential relevance to heparin mediated hemodynamic responses
    Adiguzel, C.
    Bansal, V
    Litinas, E.
    Hoppensteadt, D.
    Fareed, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 683 - 683
  • [2] Increased Anaphylatoxin (C5a) and Bradykinin Levels in Patients with End-Stage Renal Disease on Maintenance Hemodialysis: Potential Relevance to Heparin Mediated Hemodynamic Responses
    Adiguzal, Cafer
    Bansal, Vinod
    Cunanan, Josephine
    Litinas, Evangelos
    Hoppensteadt, Debra
    Fareed, Jawed
    FASEB JOURNAL, 2009, 23
  • [3] Variations in the Circulating Heparin Levels During Maintenance Hemodialysis in Patients With End-Stage Renal Disease
    Kaneva, Kristiyana
    Bansal, Vinod
    Hoppensteadt, Debra
    Cunanan, Josephine
    Fareed, Jawed
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (04) : 449 - 452
  • [4] Increased plasma adrenomedullin levels in patients with end-stage renal disease on maintenance hemodialysis:: Role of hypertension
    Cases, A
    Esforzado, N
    Vera, M
    Lario, S
    López-Pedret, J
    Jiménez, W
    Rivera-Fillat, F
    NEFROLOGIA, 2000, 20 (05): : 424 - 430
  • [5] Treatment of hepatitis C virus infection in end-stage renal disease patients on hemodialysis.
    Ferraz, MLG
    Perez, RM
    Ferreira, AP
    Khouri, ST
    Silva, IS
    Bisio, AP
    Neto, MC
    Silva, AE
    HEPATOLOGY, 2002, 36 (04) : 606A - 606A
  • [6] A dose regimen of meropenem in patients with end-stage renal disease on hemodialysis.
    Monkawa, T
    Morita, K
    Hayashi, M
    Tanigawara, Y
    Saruta, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 846A - 847A
  • [7] Variations in the Circulating Heparin Levels During Maintenance Hemodialysis in End Stage Renal Disease Patients
    Bansal, Vinod
    Kaneva, Kristiyana
    Hoppensteadt, Debra
    Cunanan, Josephine
    Fareed, Jawed
    BLOOD, 2012, 120 (21)
  • [8] Persistence of circulating heparin levels during maintenance hemodialysis in end stage renal disease patients
    Bansal, V
    Kaneva, K.
    Hoppensteadt, D.
    Cunanan, J.
    Syed, D.
    Singh, A.
    Fareed, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1090 - 1090
  • [9] Transferrin microheterogen city in patients with end stage renal disease treated by maintenance hemodialysis.
    Pietrzak, I
    Formanowicz, D
    Sobieska, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 532A - 532A
  • [10] Increased levels of LDL oxidation in patients with familial hypercholesterolemia and in end-stage renal disease patients on hemodialysis
    Van Tits, LJ
    De Graaf, J
    Bredie, SJ
    Demacker, PN
    Holvoet, P
    Stalenhoef, AF
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : A9 - A9
12345